PACLITAXEL, BEVACIZUMAB AND ADJUVANT INTRAPERITONEAL CARBOPLATIN IN TREATING PATIENTS WHO HAD INITIAL DEBULKING SURGERY FOR STAGE II, STAGE III, OR STAGE IV OVARIAN EPITHELIAL, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCER: